| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q9UI43 (MRM2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | rRNA methyltransferase 2, mitochondrial; 16S rRNA (uridine(1369)-2'-O)-methyltransferase; 16S rRNA [Um1369] 2'-O-methyltransferase; Protein ftsJ homolog 2; | |
| Q5EBL4 (RIPL1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | RILP-like protein 1; Rab-interacting lysosomal-like protein 1; | |
| Q9NUD5 (ZCHC3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger CCHC domain-containing protein 3; | |
| Q16560 (U1SBP_HUMAN) | Swiss-Prot | Homo sapiens (Human) | U11/U12 small nuclear ribonucleoprotein 35 kDa protein; Protein HM-1; U1 snRNP-binding protein homolog; | |
| Q9P1T7 (MDFIC_HUMAN) | Swiss-Prot | Homo sapiens (Human) | MyoD family inhibitor domain-containing protein; I-mfa domain-containing protein; | |
| Q9UGK3 (STAP2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Signal-transducing adaptor protein 2; Breast tumor kinase substrate; | |
| Q96GY3 (LIN37_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Protein lin-37 homolog; Antolefinin; | |
| O75586 (MED6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Mediator of RNA polymerase II transcription subunit 6; Activator-recruited cofactor 33 kDa component; Mediator complex subunit 6; Renal carcinoma antigen NY-REN-28; | |
| Q00059 (TFAM_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transcription factor A, mitochondrial; Mitochondrial transcription factor 1; Transcription factor 6; Transcription factor 6-like 2; | |
| Q99750 (MDFI_HUMAN) | Swiss-Prot | Homo sapiens (Human) | MyoD family inhibitor; Myogenic repressor I-mf; | |
| Q04917 (1433F_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 14-3-3 protein eta; Protein AS1; | |
| Q9NZH0 (GPC5B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | G protein-coupled receptor family C group 5 member B; A-69G12.1; Retinoic acid-induced gene 2 protein; | |
| Q9NXT0 (ZN586_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 586; | |
| Q8IVP9 (ZN547_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 547; | |
| H7C350 (CC188_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Coiled-coil domain-containing protein 188; | |
| P57723 (PCBP4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Poly(rC)-binding protein 4; Alpha-CP4; | |
| P20941 (PHOS_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Phosducin; 33 kDa phototransducing protein; Protein MEKA; | |
| Q6UWN0 (LYPD4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ly6/PLAUR domain-containing protein 4; | |
| Q6U7Q0 (ZN322_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 322; Zinc finger protein 322A; Zinc finger protein 388; Zinc finger protein 489; | |
| P60900 (PSA6_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Proteasome subunit alpha type-6; 27 kDa prosomal protein; Macropain iota chain; Multicatalytic endopeptidase complex iota chain; Proteasome iota chain; Proteasome subunit alpha-1; | |
| Q7L0Y3 (TM10C_HUMAN) | Swiss-Prot | Homo sapiens (Human) | tRNA methyltransferase 10 homolog C; HBV pre-S2 trans-regulated protein 2; Mitochondrial ribonuclease P protein 1; RNA (guanine-9-)-methyltransferase domain-containing protein 1; Renal carcinoma antigen NY-REN-49; mRNA methyladenosine-N(1)-methyltransferase; tRNA (adenine(9)-N(1))-methyltransferase; tRNA (guanine(9)-N(1))-methyltransferase; | |
| Q9UHR6 (ZNHI2_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger HIT domain-containing protein 2; Protein FON; | |
| Q8NEZ5 (FBX22_HUMAN) | Swiss-Prot | Homo sapiens (Human) | F-box only protein 22; F-box protein FBX22p44; | |
| Q9BUL5 (PHF23_HUMAN) | Swiss-Prot | Homo sapiens (Human) | PHD finger protein 23; PDH-containing protein JUNE-1; | |
| P14902 (I23O1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Indoleamine 2,3-dioxygenase 1; Indoleamine-pyrrole 2,3-dioxygenase; | |
| Q9BXJ4 (C1QT3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Complement C1q tumor necrosis factor-related protein 3; Collagenous repeat-containing sequence 26 kDa protein; Secretory protein CORS26; | |
| P61328 (FGF12_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Fibroblast growth factor 12; Fibroblast growth factor homologous factor 1; Myocyte-activating factor; | |
| Q5VUY2 (ADCL4_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Arylacetamide deacetylase-like 4; | |
| Q6P2D0 (ZFP1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 1 homolog; Zinc finger protein 475; | |
| Q86VZ6 (JAZF1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Juxtaposed with another zinc finger protein 1; TAK1-interacting protein 27; Zinc finger protein 802; | |
| Q9H707 (ZN552_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 552; | |
| Q9NSI5 (IGSF5_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Immunoglobulin superfamily member 5; Junctional adhesion molecule 4; | |
| Q8NBT0 (POC1A_HUMAN) | Swiss-Prot | Homo sapiens (Human) | POC1 centriolar protein homolog A; Pix2; Proteome of centriole protein 1A; WD repeat-containing protein 51A; | |
| P09326 (CD48_HUMAN) | Swiss-Prot | Homo sapiens (Human) | CD48 antigen; B-lymphocyte activation marker BLAST-1; BCM1 surface antigen; Leukocyte antigen MEM-102; SLAM family member 2; Signaling lymphocytic activation molecule 2; TCT.1; CD48; | |
| Q5TBK1 (N42L1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | NEDD4-binding protein 2-like 1; | |
| O14874 (BCKD_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Branched-chain alpha-ketoacid dehydrogenase kinase; [3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial; | |
| Q9ULX3 (NOB1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | RNA-binding protein NOB1; Phosphorylation regulatory protein HP-10; Protein ART-4; | |
| Q13702 (RAPSN_HUMAN) | Swiss-Prot | Homo sapiens (Human) | 43 kDa receptor-associated protein of the synapse; 43 kDa postsynaptic protein; Acetylcholine receptor-associated 43 kDa protein; RING finger protein 205; | |
| Q3ZCT1 (ZN260_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 260; | |
| Q14318 (FKBP8_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Peptidyl-prolyl cis-trans isomerase FKBP8; 38 kDa FK506-binding protein; FK506-binding protein 8; FKBPR38; Rotamase; | |
| Q401N2 (ZACN_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Ligand-gated cation channel ZACN; Ligand-gated ion channel zinc-activated 1; Ligand-gated ion-channel receptor L2; Zinc-activated channel; | |
| P0CB33 (ZN735_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 735; | |
| P10600 (TGFB3_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Transforming growth factor beta-3 proprotein; Latency-associated peptide; LAP; Transforming growth factor beta-3; TGF-beta-3; | |
| P16219 (ACADS_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Short-chain specific acyl-CoA dehydrogenase, mitochondrial; Butyryl-CoA dehydrogenase; | |
| P00966 (ASSY_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Argininosuccinate synthase; Citrulline--aspartate ligase; | |
| Q14184 (DOC2B_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Double C2-like domain-containing protein beta; | |
| O75541 (ZN821_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Zinc finger protein 821; | |
| Q9NVG8 (TBC13_HUMAN) | Swiss-Prot | Homo sapiens (Human) | TBC1 domain family member 13; | |
| P35372 (OPRM_HUMAN) | Swiss-Prot | Homo sapiens (Human) | Mu-type opioid receptor; Mu opiate receptor; Mu opioid receptor; | |
| Q9GZV5 (WWTR1_HUMAN) | Swiss-Prot | Homo sapiens (Human) | WW domain-containing transcription regulator protein 1; Transcriptional coactivator with PDZ-binding motif; |
Homo sapiens (Latin: "wise man") is the species name for humans. Believed to have originated in Africa, Homo sapiens is the only surviving member of the Homo genus.
The first complete draft of the human genome was completed in 2001 with an estimated cost of $300million. With the advances in DNA sequencing methods, this price has dropped dramatically down to almost $1000 per genome. By combining the individual genome information with other data, such as protein structure models, personalised medicine becomes viable.
From left to right: i) The number of proteins in the reference proteome of Homo sapiens, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Homo sapiens for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Homo sapiens, please visit Proteome.
You can easily download the latest protein sequences for Homo sapiens proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_02 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 20,652 | 17,815 | 43,031 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Homo sapiens reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Homo sapiens proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 11-mer | 12-mer | 13-mer | 14-mer | 15-mer | 16-mer | 18-mer | 20-mer | 21-mer | 22-mer | 24-mer | 25-mer | 26-mer | 30-mer | 32-mer | 33-mer | 34-mer | 36-mer | 39-mer | 40-mer | 44-mer | 48-mer | 51-mer | 56-mer | 60-mer | 62-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38,374 | 3,279 | 317 | 620 | 61 | 135 | 14 | 51 | 2 | 21 | 8 | 46 | 1 | 5 | 2 | 22 | 8 | 2 | 1 | 2 | 17 | 2 | 2 | 1 | 3 | 1 | 1 | 2 | 1 | 7 | 1 | 5 | 1 | 1 | 13 | 2 |
